vascular access News
-
Bluegrass Vascular Announces Publication Reporting Long-term data following facilitation of HeRO graft placement using the Surfacer System
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of a report three cases where the Surfacer System was used to help facilitate the placement of the HeRO graft in patients with thoracic central venous obstruction (TCVO) where other methods for crossing the ...
-
Cincinnati Children`s Launches Innovative Device Startup, Xact Medical
Cincinnati Children's Hospital Medical Center and Ben Gurion University in Israel today launched Xact Medical, a new company the hospital and University formed to commercialize the FIND system—Fast Intelligent Needle Delivery. FIND extends and enhances clinician capabilities and control for precisely, quickly, and conveniently placing a needle tip at a point in the body that ...
-
Velano’s Vascular Access Technologies Help Hospitals Meet 2021 Infusion Therapy Standards of Practice
Vascular access technology pioneer Velano Vascular today revealed that the 2021 Infusion Therapy Standards of Practice, 8th Ed., include its needle free PIVO™ device and evidence of the procedure’s improved performance for inpatient blood draws. Updated every five years and considered the preeminent guidance for infusion therapy, the newly reset standards from the Infusion Nurses ...
-
Saranas® Expands Intellectual Property with Key Patent Integrating Bleed Monitoring and Vascular Access Closure Device
Saranas, a company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications, announced today that the U.S. Department of Commerce’s United States Patent and Trademark Office (USPTO) has issued them Patent No. 11,224,414. Titled “Access Closure with Bleed Monitoring,” this key patent allows for embedding a vascular access ...
-
Velano Secures Additional Funding to Meet Commercial Demand for PIVO, Fueled by Industry Move to One-Stick Hospitalization
SAN FRANCISCO, Dec. 17, 2019 (GLOBE NEWSWIRE) — Vascular access technology pioneer Velano Vascular today announced that it has closed the second tranche of a $25 million growth financing that will fuel commercialization and the launch of additional novel inpatient medical device solutions. This new investment builds on an initial tranche closed in the first half of 2019 and brings ...
-
New Study Shows Advantages of Ellipsys System in Safely and Quickly Creating Reliable Dialysis Access
A new study shows significant benefits of the Ellipsys Vascular Access System in easily and safely creating durable vascular access for end-stage renal disease (ESRD) patients who require hemodialysis. It also offers a standardized process for using the minimally invasive technology that other physicians can follow to reproduce the results, which “will make it easier for more practitioners ...
-
Two-year Ellipsys data featured at annual Controversies in Dialysis Access (CiDA) Meeting
A landmark two-year follow-up study on the Ellipsys® Vascular Access System was highlighted at the annual Controversies in Dialysis Access (CiDA) meeting, one of the premier dialysis access medical conferences in the world. The Ellipsys System from Avenu Medical is a non-surgical alternative to creating vascular access for end-stage renal disease (ESRD) patients who require hemodialysis. It ...
-
Second Patent Issued for Healionics’ Textured STAR Biointerface
Healionics Corporation has received a further patent for its textured STAR Biointerface technology. The United States Patent and Trademark Office issued Patent No. 8,647,393, "Implantable Medical Devices Having Microporous Surface Layers and Method for Reducing Foreign Body Response to the Same.” This new patent extends the scope of 8,372,423 issued to Healionics in February 2013. The STAR ...
By Healionics
-
Velano’s Vascular Access Technologies Help Hospitals Meet 2021 Infusion Therapy Standards of Practice
SAN FRANCISCO, January 25, 2021 — Vascular access technology pioneer Velano Vascular today revealed that the 2021 Infusion Therapy Standards of Practice, 8th Ed., include its needle free PIVO™ device and evidence of the procedure’s improved performance for inpatient blood draws. Updated every five years and considered the preeminent guidance for infusion therapy, the newly reset ...
-
Ellipsys System Offers Significant Advantages for Creating Dialysis Access, Physicians Say
The Ellipsys® Vascular Access System enables patients with kidney failure to start dialysis treatment sooner with fewer procedures, complications and interventions compared to surgery, according to several leading physicians who spoke at the recent meeting of the American Society of Diagnostic and Interventional Nephrology (ASDIN). Interventional radiologist Jeffrey Hull, M.D., was awarded ...
-
Novel Securement Device Making Inroads
AVA Scientific Meeting 2019 highlights key opportunities for improvement in vascular access from process bundles to emerging new products Introduction Acknowledgment of the importance of the vascular access nurse and team were obvious at this year’s Association for Vascular Access (AVA) Annual Scientific meeting. When Ramzy Nasrallah took over as CEO for the Association of Vascular Access ...
-
Healionics Awarded $1.7M SBIR Grant from NIH to Advance New Vascular Graft Toward First-In-Human Use
Healionics Corporation, a Seattle-based medical device company, has received notice from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of a $1.7M Fast-Track Small Business Innovation Research (SBIR) grant in support of regulatory approval and a clinical study of STARgraftTM, its innovative synthetic vascular graft. Andrew Marshall, Healionics’ Chief Technology ...
By Healionics
-
Bluegrass Vascular Announces Featured Paper in the Journal of Vascular Surgery Reporting on the Use of the Surfacer System
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of a paper featured on the cover of the June 2022 issue of the Journal of Vascular Surgery (JVS) which reports on the use the Surfacer System to perform an Inside-Out® procedure to obtain central venous ...
-
Bluegrass Vascular Announces New Paper Reporting Use of the Surfacer System via Transcollateral Approach
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of a paper reporting on the use of the Surfacer® System to perform the Inside-Out® procedure via transcollateral approach. “The Surfacer Inside-out system represents a new approach to restore ...
-
Velano Vascular Named Top Impact Company for 2021 by Real Leaders
Vascular access technology pioneer Velano Vascular was today named a Top Impact Company for 2021 by Real Leaders, the world’s first business and sustainable leadership magazine. Velano was recognized alongside such notable brands as Tesla, Beyond Meat, and Patagonia on the 2021 list for its work making hospital stays more humane and less risky for both patients and practitioners. Through ...
-
IV Dislodgement Is a Common Problem in Vascular Access, Clinicians Say
Portsmouth, N.H. – IV dislodgement is a near-daily problem for clinicians and their patients, according to a recent focus group of vascular access experts. The clinicians also reported there is a need for better technology to mitigate the potentially serious consequences of frequent IV dislodgements. “This research discussion addressed a frustrating problem that those of us in ...
-
Minimally Invasive Ellipsys System Creates Fused, Permanent Vascular Access for Dialysis
A new case report published in the Journal of Vascular Surgery provides one of the first known opportunities to directly visualize the permanent and fused connection (anastomosis) that is created with the minimally invasive Ellipsys® Vascular Access System. The Ellipsys System, made by Avenu Medical, creates a type of dialysis access known as a percutaneous arteriovenous fistula (pAVF) for ...
-
Bluegrass Vascular Announces Publication of Surfacer System SAVE Registry Results
Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of the results from the company’s prospective, multicenter SAVE (Surfacer® System to Facilitate Access in VEnous Occlusions) Registry in the Journal of Vascular and Interventional ...
-
Bluegrass Vascular Technologies Announces Publication of Surfacer System IDE Study Results
Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of the results of its prospective, multicenter SAVE-US (Surfacer® System to Facilitate Access in VEnous Occlusions – United States) study in the Journal of Vascular Access. This ...
-
Healionics Announces New CEO
Healionics Corporation, a Seattle-based medical device company, today announced the appointment of Mike Connolly as Chief Executive Officer. Connolly brings 25 years of leadership in the medical device industry including extensive experience in both operating and venture investing roles. “We are fortunate to add a leader of Mike’s caliber,” said Andrew Marshall, Director and ...
By Healionics
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you